DOES EARLY IMMUNOSUPPRESSIVE THERAPY PREVENT SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE?

被引：0
|
作者：
Velauthapillai, A. [1 ]
Bootsma, M. [1 ]
Bruni, C. [2 ]
Distler, O. [2 ]
Van den Ende, C. [1 ]
Vonk, M. [1 ]
机构：
[1] Radboud Univ Nijmegen, Rheumatol, Med Ctr, Nijmegen, Netherlands
[2] Univ Hosp Zurich, Rheumatol, Zurich, Switzerland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Systemic sclerosis; Lungs; Epidemiology;
D O I：
10.1136/annrheumdis-2023-eular.1277
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0239
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [21] Disease staging and sub setting of interstitial lung disease associated with systemic sclerosis: impact on therapy
    George, Peter M.
    Wells, Athol U.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (02) : 127 - 135
  • [22] Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease
    Roofeh, David
    Lin, Celia J. F.
    Goldin, Jonathan
    Kim, Grace Hyun
    Furst, Daniel E.
    Denton, Christopher P.
    Huang, Suiyuan
    Khanna, Dinesh
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (07) : 1301 - 1310
  • [23] RITUXIMAB AS RESCUE THERAPY IN ADVANCED PROGRESSIVE SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE
    Kokosi, M.
    Saunders, P.
    Karagiannis, K.
    Chua, F.
    Maher, T. M.
    Renzoni, E. A.
    Wells, A. U.
    THORAX, 2015, 70 : A92 - A92
  • [24] Challenges in evidence-based therapy for systemic sclerosis associated interstitial lung disease
    Denton, Christopher P.
    Ong, Voon H.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (03): : 226 - 227
  • [25] Lung transplantation for systemic sclerosis-associated interstitial lung disease
    Le Pavec, J.
    Launay, D.
    Cottin, V.
    Reynaud-Gaubert, M.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 : E73 - E79
  • [26] Lung Function And Survival In Systemic Sclerosis Associated Interstitial Lung Disease
    Shadly, S. M.
    Johnson, S. R.
    Chau, C.
    Marras, T. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [27] Relevance of immunomodulatory therapy for interstitial lung disease in systemic sclerosis
    Aringer, Martin
    Riemekasten, Gabriela
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2021, 35 (03):
  • [28] Experience with azathioprine in systemic sclerosis associated with interstitial lung disease
    K. Dheda
    U. G. Lalloo
    B. Cassim
    G. M. Mody
    Clinical Rheumatology, 2004, 23 : 306 - 309
  • [29] Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis
    Tochimoto, Akiko
    Kawaguchi, Yasushi
    Yamanaka, Hisashi
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2015, 9 : 135 - 140
  • [30] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
    Distler, Oliver
    Highland, Kristin B.
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen D.
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Alves, Margarida
    Clerisme-Beaty, Emmanuelle
    Stowasser, Susanne
    Tetzlaff, Kay
    Kuwana, Masataka
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26): : 2518 - 2528
12345